Skip to content

Perioperative Hyperglycaemia in Primary Total Hip and Knee Replacement

Determinants of Perioperative Hyperglycaemia in Primary Hip and Knee Replacement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01021826
Acronym
HyTe-1
Enrollment
193
Registered
2009-11-30
Start date
2009-12-31
Completion date
2012-09-30
Last updated
2015-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Replacement, Hyperglycemia, Knee Replacement

Keywords

knee replacement, hip replacement, hyperglycemia, diabetes, osteoarthritis

Brief summary

The purpose of this study is to analyze how common stress hyperglycaemia (abnormally high blood glucose) is in primary hip and knee replacement surgeries and which factors predispose to hyperglycaemia.

Detailed description

Postoperative infections remain one of the most frequent reasons of failure of hip and knee prostheses. Diabetes increases the risk of infections. In other fields of surgery, hyperglycemia induced by surgical stress (stress/perioperative hyperglycemia) has been associated with higher rates of postoperative infections and complications. Such studies have not yet been performed in the field of joint replacement surgery. Unlike several other risk factors of infected joint replacements, hyperglycemia is potentially modifiable and therefore its prevalence, predisposing factors and association with postoperative infections are of interest.

Interventions

None listed

Sponsors

Tampere University
CollaboratorOTHER
Coxa, Hospital for Joint Replacement
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of osteoarthritis * Scheduled for primary hip or knee replacement

Exclusion criteria

* Arthritis other than osteoarthritis * Medication affecting glucose metabolism (excl. antidiabetic agents) * Not undergoing hip or knee replacement

Design outcomes

Primary

MeasureTime frameDescription
Occurrence (and severity) of hyperglycemia following primary hip or knee replacement3 days (average)Follow-up covers postoperative hospital stay at the operating hospital, that lasts typically 2-5 days.

Secondary

MeasureTime frame
Incidence of surgical-site infections1 year
Prevalence of glucose metabolism disorders and metabolic syndromeBaseline

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026